Global Blood Group Typing Product Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Instruments, Reagents, and KitsBy Technique;
Serology Tests and Molecular TestsBy Type;
Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, and Antigen TypingBy End User;
Hospitals, Clinical Laboratories, Blood Banks, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Blood Group Typing Product Market Overview
Blood Group Typing Product Market (USD Million)
Blood Group Typing Product Market was valued at USD 3,150.66 million in the year 2024. The size of this market is expected to increase to USD 6,023.49 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.7%.
Global Blood Group Typing Product Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 9.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 9.7 % |
Market Size (2024) | USD 3,150.66 Million |
Market Size (2031) | USD 6,023.49 Million |
Market Concentration | Medium |
Report Pages | 372 |
Major Players
- Immucor
- Merck KGaA
- Novacyt Group
- Quotient
- Ortho Clinical Diagnostics
- Bag Health Care GmbH
- Rapid Labs
- AXO Science
- Agena Bioscience
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Blood Group Typing Product Market
Fragmented - Highly competitive market without dominant players
The Blood Group Typing Product Market is undergoing significant growth, driven by the rising importance of safe blood transfusions and pre-procedure testing. The global shift toward patient-specific therapies has resulted in a 15% increase in the adoption of typing products. Enhanced awareness and improved healthcare workflows are propelling this expansion across clinical settings.
Technological Advancements
The integration of automated platforms and DNA-based methods has transformed the accuracy and speed of blood group testing. The application of these cutting-edge tools has triggered a 20% surge in demand for precision reagents and instruments. These solutions are instrumental in delivering quicker diagnostics and reducing potential risks.
Use in Specialized Medical Practices
Specialized areas like prenatal diagnostics and organ transplantation have amplified the use of typing products, contributing to a 17% increase in dedicated testing kits. These applications ensure compatibility and minimize immune reactions, reinforcing the value of accurate typing in complex cases.
Market Momentum and Innovations
Ongoing research and healthcare policy support are fueling market expansion. With a 16% uptick in adoption among laboratories, supported by automation and real-time diagnostics, the market is well-positioned for continued growth. Innovations and educational initiatives are shaping a future-focused, safety-driven market landscape.
Blood Group Typing Product Market Recent Developments
-
In March 2021, Bio‑Rad Laboratories teamed up with Roche to integrate InteliQ blood typing tools and Unity QC data management into Roche’s systems, enhancing streamlined serological and molecular typing workflows.
-
In June 2023, Quotient Limited earned CE certification for its MosaiQ extended immunohematology microarray, enabling unified donor genotyping and antibody screening on a single high-throughput platform.
Blood Group Typing Product Market Segment Analysis
In this report, the Blood Group Typing Product Market has been segmented by Product, Technique, Type, End User, and Geography.
Blood Group Typing Product Market, Segmentation by Product
The Blood Group Typing Product Market has been segmented by Product into Instruments, and Reagents, and Kits.
Instruments
Blood group typing instruments, such as automated analyzers and semi-automated systems, streamline testing processes and improve accuracy. They account for over 40% of the market, driven by increasing automation in diagnostic laboratories and hospitals.
Reagents
Reagents are vital for detecting antigens and antibodies in blood samples. Their recurring use in both manual and automated testing makes them indispensable, contributing to approximately 35% of the market. Growth is supported by rising blood donation activities and transfusion procedures.
Kits
Blood typing kits offer a complete package for quick and reliable testing, especially in point-of-care settings and emergency situations. They represent around 25% of the market and are favored for their portability, ease of use, and rapid results.
Blood Group Typing Product Market, Segmentation by Technique
The Blood Group Typing Product Market has been segmented by Technique into Serology Tests, and Molecular Tests.
Serology Tests
Serology tests are the most widely used technique for blood group typing, relying on antigen-antibody reactions to detect ABO and Rh factors. These tests are fast, cost-effective, and widely adopted in blood banks and clinical laboratories. This segment holds 70% of the market share.
Molecular Tests
Molecular tests use DNA-based techniques such as PCR and microarray analysis to provide high-resolution blood typing. They are especially valuable in complex cases or when serological methods are inconclusive. This segment accounts for 30% of the market share.
Blood Group Typing Product Market, Segmentation by Type
The Blood Group Typing Product Market has been segmented by Type into Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, and Antigen Typing.
Antibody Screening
Antibody screening is crucial for detecting unexpected antibodies in the blood, especially before blood transfusions or organ transplants. It ensures compatibility and safety in transfusion procedures. This segment holds 25% of the market share.
HLA Typing
HLA typing is essential for matching donors and recipients in organ and bone marrow transplantation. It uses advanced molecular diagnostics to ensure genetic compatibility and prevent rejection. This segment accounts for 20% of the market share.
ABO Blood Tests
ABO blood tests are the most common and fundamental type of blood group typing, used in virtually all transfusion and donation settings. They determine an individual's ABO and Rh status. This segment represents 30% of the market share.
Cross-Matching Tests
Cross-matching tests verify the compatibility between a donor’s red blood cells and the recipient’s plasma to prevent transfusion reactions. They are widely used in hospital blood banks. This segment holds 15% of the market share.
Antigen Typing
Antigen typing involves identifying minor blood group antigens beyond ABO and Rh, which is important in multi-transfused patients and for rare blood type identification. This segment contributes 10% of the market share.
Blood Group Typing Product Market, Segmentation by End User
The Blood Group Typing Product Market has been segmented by End User into Hospitals, Clinical Laboratories, Blood Banks, and Others.
Hospitals
Hospitals are major users of blood group typing products for pre-surgical testing, emergency transfusions, and routine patient diagnostics. They depend on accurate and rapid testing to ensure transfusion safety. This segment holds 35% of the market share.
Clinical Laboratories
Clinical laboratories perform a wide range of diagnostic blood tests, including ABO typing and antibody screening. These facilities support both hospital-based and outpatient diagnostics. This segment accounts for 25% of the market share.
Blood Banks
Blood banks are critical end users of typing products, as they must screen and label donor blood with precise blood group information. They also use these tools for cross-matching and inventory management. This segment represents 30% of the market share.
Others
This category includes research institutions, military health centers, and ambulatory care units that require blood group typing for specialized or decentralized diagnostic needs. This segment holds 10% of the market share.
Blood Group Typing Product Market, Segmentation by Geography
In this report, the Blood Group Typing Product Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
Blood Group Typing Product Market Share (%)by Geographical Region
North America
North America leads the blood group typing product market due to advanced healthcare infrastructure, high demand for safe transfusion practices, and regular blood donation campaigns. The United States and Canada are the main contributors, with widespread use of automated typing instruments. This region holds 38% of the market share.
Europe
Europe maintains strong market growth supported by well-established blood screening regulations and a high number of blood transfusions. Countries like Germany, France, and the United Kingdom lead in adoption of molecular and serological testing. This region accounts for 30% of the market share.
Asia Pacific
Asia Pacific is rapidly expanding due to growing population base, increased awareness of safe transfusion practices, and improving diagnostic infrastructure. Major contributors include China, India, and Japan. This region represents 22% of the market share.
Middle East and Africa
The Middle East and Africa region is experiencing gradual growth driven by increasing healthcare investments and improved access to blood typing solutions in both urban and rural areas. Countries such as Saudi Arabia, UAE, and South Africa are key markets. This region holds 6% of the market share.
Latin America
Latin America is growing steadily due to enhanced public health initiatives, expanded diagnostic services, and rising blood donation programs. Key countries include Brazil, Mexico, and Argentina. This region accounts for 4% of the market share.
Blood Group Typing Product Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Blood Group Typing Product Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising Incidence of Hematological Disorders
- Growing Geriatric Population
- Technological Advancements in Blood Typing Techniques
-
Rising Awareness About Blood Donation and Safety - The Blood Group Typing Product Market. Public health campaigns, awareness weeks, and education initiatives by governments and NGOs have made individuals more conscious of the critical role blood donation plays in saving lives. As a result, more people are participating in blood donation drives, which has elevated the demand for accurate and timely blood group typing to ensure compatibility and safety.
Blood safety is a top priority for healthcare providers and transfusion centers worldwide. Ensuring that donated blood is properly typed before transfusion helps prevent serious complications such as transfusion reactions or alloimmunization. This necessity is driving the adoption of advanced typing systems and reagents that offer higher precision and faster turnaround times. As safety protocols become more stringent, institutions are investing in dependable blood group typing products to meet regulatory standards and improve patient outcomes.
Media coverage of the importance of blood availability during emergencies and surgical procedures has also helped sustain awareness, leading to a steady increase in voluntary donations. The rise in complex surgical interventions and trauma care has further reinforced the need for rapid and reliable blood typing. Hospitals and diagnostic labs are expanding their use of automated typing platforms and point-of-care solutions to meet growing demands efficiently.
As the public continues to recognize the impact of safe blood donation on community health, the market for blood group typing products is expected to maintain strong momentum. This rising awareness, supported by better infrastructure and evolving technologies, ensures continued relevance and demand for accurate, high-throughput typing solutions.
Restraints
- Stringent Regulatory Requirements
- Limited Access to Healthcare in Developing Regions
- Risk of Transfusion Reactions and Errors
-
Competition from Alternative Blood Typing Methods - Technological advancements have introduced newer diagnostic techniques such as genotyping and molecular-based typing, which offer enhanced accuracy, especially in complex transfusion cases. These modern alternatives are gaining traction, particularly in specialized clinical settings, leading to a gradual shift away from traditional serological methods and limiting the demand for conventional blood group typing products.
Molecular diagnostics, though more expensive, provide deeper insights into blood group antigens and help resolve discrepancies that standard techniques may miss. For immunohematology labs handling difficult cases—such as those involving rare blood types or patients with multiple transfusions—these tools are becoming the preferred choice. As a result, traditional product manufacturers face pressure to innovate and compete with these emerging methods, which are slowly becoming more affordable and accessible.
Additionally, some regions are investing heavily in next-generation laboratory infrastructure, equipping centers with automated platforms capable of integrating advanced testing techniques. This transformation is encouraging the adoption of newer solutions, reducing the reliance on legacy systems. As hospitals prioritize comprehensive and precise diagnostics, especially for at-risk patient populations, the competitive threat posed by these alternatives continues to grow.
To maintain market relevance, traditional typing product manufacturers must adapt by integrating automation, enhancing reagent sensitivity, and aligning with evolving diagnostic workflows. Without such innovation, competition from advanced methods could further limit the growth potential of established blood typing solutions.
Opportunities
- Development of Point-of-Care Testing Solutions
- Adoption of Automation and Robotics
- Integration with Molecular Diagnostics
-
Focus on Personalized Medicine and Blood Matching - The Blood Group Typing Product Market. As healthcare shifts toward individualized treatment approaches, precise blood typing becomes essential for tailoring therapies, especially for patients with complex transfusion needs or those undergoing bone marrow and organ transplants. Personalized medicine emphasizes compatibility at a genetic and antigenic level, driving the need for more advanced blood typing systems capable of detailed and accurate profiling.
This trend has led to a rising demand for molecular blood typing techniques that can detect subtle antigenic variations not typically identified by traditional serological methods. These technologies are especially useful for chronically transfused patients who are more likely to develop alloantibodies. By enabling better donor-patient matching, such innovations reduce the risk of transfusion reactions and enhance long-term clinical outcomes. As precision medicine gains momentum globally, blood group typing products are being integrated into broader diagnostic workflows to support safer, personalized care.
Healthcare providers and research institutions are also investing in automated blood typing platforms to manage high volumes of patient data efficiently and ensure accuracy. These systems are increasingly adopted in hospitals, specialty labs, and blood banks to meet the demands of modern healthcare delivery. As AI and data analytics begin playing a larger role in clinical decision-making, the inclusion of precise blood group data is becoming a standard part of personalized health records.
This growing convergence of personalized medicine and transfusion safety opens up long-term opportunities for innovation and market expansion. Manufacturers focusing on advanced compatibility solutions, genomic typing, and seamless lab integration are well-positioned to benefit from this evolving healthcare paradigm.
Blood Group Typing Product Market Competitive Landscape Analysis
Key players in Blood Group Typing Product Market include :
- Bio‑Rad Laboratories
- Grifols S.A.
- Ortho Clinical Diagnostics (QuidelOrtho)
- Immucor, Inc.
- Danaher Corporation (Beckman Coulter)
- Thermo Fisher Scientific
- Quotient Limited
- CareDx Inc.
- Agena Bioscience, Inc.
- Merck KGaA
- Novacyt Group
- Seegene Inc.
- Rapid Labs Ltd.
- BAG Health Care GmbH
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technique
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Blood Group Typing Product Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising blood transfusion procedures worldwide
- Increasing prenatal testing and screening rates
- Growth in organ transplantation activities
- Demand for safe blood compatibility testing
- Restraints
- High cost of advanced typing technologies
- Shortage of skilled lab professionals
- Inconsistent quality in blood sample handling
- Regulatory hurdles in diagnostic device approval
- Opportunities
- Automation in blood typing procedures
- Expansion in emerging healthcare markets
- Development of rapid point-of-care tests
- Integration with electronic health record systems
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Blood Group Typing Product Market, By Product, 2021 - 2031 (USD Million)
- Instruments
- Reagents
- Kits
- Blood Group Typing Product Market, By Technique, 2021 - 2031 (USD Million)
- Serology Tests
- Molecular Tests
- Blood Group Typing Product Market, By Type, 2021 - 2031 (USD Million)
- Antibody Screening
- HLA Typing
- ABO Blood Tests
- Cross-Matching Tests
- Antigen Typing
- Blood Group Typing Product Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Clinical Laboratories
- Blood Banks
- Others
- Blood Group Typing Product Market Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Blood Group Typing Product Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Bio‑Rad Laboratories
- Grifols S.A.
- Ortho Clinical Diagnostics (QuidelOrtho)
- Immucor, Inc.
- Danaher Corporation (Beckman Coulter)
- Thermo Fisher Scientific
- Quotient Limited
- CareDx Inc.
- Agena Bioscience, Inc.
- Merck KGaA
- Novacyt Group
- Seegene Inc.
- Rapid Labs Ltd.
- BAG Health Care GmbH
- Company Profiles
- Analyst Views
- Future Outlook of the Market